Drug Profile
SAR 7226
Alternative Names: SAR7226Latest Information Update: 26 Jan 2010
Price :
$50
*
At a glance
- Originator sanofi-aventis
- Class Antihypoglycaemics
- Mechanism of Action Sodium-glucose transporter 1 inhibitors; Sodium-glucose transporter 2 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Type 2 diabetes mellitus